Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 4:11 PM
Ignite Modification Date:
2025-12-25 @ 2:11 PM
NCT ID:
NCT02668666
Group ID:
EG000
Title:
Investigational Treatment
Description:
Subjects will be enrolled to determine progression-free survival (PFS) in subjects with HR(+)/HER2(-) advanced breast cancer who have not received prior systemic anti-cancer therapies.
Palbociclib 125 mg will be administered orally once daily on days D1-D21 of each 28-day cycle. Subjects will not take palbociclib on D22-D28.
Tamoxifen 20 mg will be administered orally once daily for every day of the 28-day cycle (i.e., continuously).
Palbociclib: Palbociclib 125 mg will be administered orally once daily on days D1-D21 of each 28-day cycle. Subjects will not take palbociclib on D22-D28.
Tamoxifen: Tamoxifen 20 mg will be administered orally once daily for every day of the 28-day cycle (i.e., continuously).
Deaths Number Affected:
16
Deaths Number At Risk:
None
Serious Number Affected:
16
Serious Number At Risk:
49
Other Number Affected:
49
Other Number At Risk:
49
Study:
NCT02668666
Results Section:
NCT02668666
Adverse Events Module:
NCT02668666